Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire BRIDGEWATER, N.J., July 10, 2024 Customers will start receiving shipments...
Majority of patients in this age group with eosinophilic esophagitis (EoE) receiving Dupixent achieved...
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer PR Newswire ROCKVILLE, Md., June 6, 2024...
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark...
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN...
If approved, Dupixent would be the first treatment in the U.S. indicated for adolescents aged 12-17 years with...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.